ScienceDaily: Heart Disease News

Researchers have demonstrated that the recently developed antidiabetic drug empagliflozin can treat and reverse the progression of heart failure in non-diabetic animal models. Their study also shows that this drug can make the heart produce more energy and function more efficiently.

People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack.

Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

Every heart beat sends blood flowing throughout the human body. While an electrocardiogram uses a contact approach to measure the electrical activity of the heart, a ballistocardiogram is a non-contact way of measuring the mechanical effect of the blood flow through the cardiovascular system.

Two proteins that bind to stress hormones work together to maintain a healthy heart in mice, according to scientists. These proteins, stress hormone receptors known as the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), act in concert to help support heart health. When the signaling between the two receptors is out of balance, the mice have heart disease.

Half of patients prescribed statins in primary care fail to reach 'healthy' cholesterol levels after two years of treatment with these drugs.

A resting heart rate of 75 beats per minute in mid-life is linked to a doubling in the risk of an early death from all causes -- at least among men.

A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.

In a major medical breakthrough, researchers have 'printed' the world's first 3D vascularised engineered heart using a patient's own cells and biological materials.

Combining a high-fat diet with a drug that raises blood pressure gave researchers a 'two-hit' model, like a one-two punch to heart failure.

Doxorubicin (Doxo) is a widely used chemotherapeutic drug for cancer, though it can have toxic effects on the heart. A recent animal study investigated whether the cardioregulatory protein chromogranin A (CgA) contributes to the regulation of the cardiotoxic and antitumor activities of Doxo.

Chronic diseases are a key factor limiting the mobility of older people. Usually individuals are conscious of their condition in the case of an acute musculoskeletal disorder that causes pain or functional limitations. However, if the condition has progressed slowly, the gradual restriction of mobility often goes unnoticed.

A new algorithm can determine whether a patient is likely to have a cholesterol-raising genetic disease that can cause early, and sometimes fatal, heart problems, reports a new study.

Heart attack patients with the desire to return to work can do it. That's the main message of a paper published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC). 'Patients who believe they can still do their job and want to go back will make a success of it,' said lead author Dr. Rona Reibis, of the University of Potsdam, Germany.

Stress-related disorders -- conditions triggered by a significant life event or trauma -- may be linked to a heightened risk of cardiovascular disease (CVD), finds a large study.

Lowering low-density lipoprotein (LDL) cholesterol reduces the risk of heart attacks and stroke, with an ideal value below 100 milligrams per deciliter (mg/dL). But can it be too low? A new study finds that women who have levels of LDL cholesterol 70 mg/dL or lower may be more than twice as likely to have a hemorrhagic stroke than women with LDL cholesterol levels from 100 to 130 mg/dL.

Investigators have found evidence that the gene Ccdc117 supports the rapid growth of precursor cells needed for proper development of right-sided heart structures. It does so by promoting transfer of iron-sulfur compounds to enzymes crucial for DNA replication and repair. Silencing Ccdc117 impedes cell growth, which may prevent heart structures from developing properly.

Although melatonin does improve the outcomes of induced heart attacks in rats, those improvements are not the result of its antioxidant effect, new research finds.

Five minutes daily of Inspiratory Muscle Strength Training lowers blood pressure, improves vascular health, boosts fitness and sharpens memory, according to preliminary results.